Evidence map›Paper›PMID 36539908›Full record

ReviewCancer imaging : the official publication of the International Cancer Imaging Society2022

Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [

E Lopci, N Aide, A Dimitrakopoulou-Strauss, L Dercle, A Iravani, R D Seban, C Sachpekidis, O Humbert, O Gheysens, A W J M Glaudemans and 6 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancer imaging : the official publication of the International Cancer Imaging Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Approaches to Imaging Immune Activation Using PET.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Review
  3. Article
  4. [European journal of nuclear medicine and molecular imaging · 2024
    Article
  5. Review
  6. Review
  7. Organ-specific accuracy of [Japanese journal of radiology · 2024
    Article
  8. Integrating [Cancers · 2023
    Article
  9. [Diagnostics (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

E LopciNuclear Medicine Unit, IRCCS - Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, MI, Italy. egesta.lopci@gmail.com.ORCID http://orcid.org/0000-0001-9732-1094
N AideNuclear Medicine Department, University Hospital, Caen, France.
A Dimitrakopoulou-StraussClinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69210, Heidelberg, Germany.
L DercleDepartment of Radiology, New York Presbyterian, Columbia University Irving Medical Center, New York, NY, USA.
A IravaniDepartment of Radiology, The University of Washington, Seattle, USA.
R D SebanDepartment of Nuclear Medicine and Endocrine Oncology, Institut Curie, 92210, Saint-Cloud, France.
C SachpekidisClinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69210, Heidelberg, Germany.
O HumbertDepartment of Nuclear Medicine, Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France.
O GheysensDepartment of Nuclear Medicine, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.
A W J M GlaudemansNuclear Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
W A WeberDepartment of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Ismaninger Str. 22, 81675, Munich, Germany.
A D Van den AbbeeleDepartment of Imaging, Dana-Farber Cancer Institute and Department of Radiology, Mass General Brigham Hospitals, Harvard Medical School, Boston, MA, USA.
R L WahlMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
A M ScottDepartment of Molecular Imaging and Therapy, Austin Health, Studley Rd, Heidelberg, VIC, 3084, Australia.
N Pandit-TaskarMolecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA.
R J HicksThe Department of Medicine, St Vincent's Medical School, the University of Melbourne, Melbourne, Australia.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Response assessment in the context of immunomodulatory treatments represents a major challenge for the medical imaging community and requires a multidisciplinary approach with involvement of oncologists, radiologists, and nuclear medicine specialists. There is evolving evidence that [

Indexed as

NeoplasmsPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18HumansPositron-Emission TomographyRadiopharmaceuticalsReference StandardsFluorodeoxyglucose F18Radiopharmaceuticals[18F]FDGGuidelineImmunotherapyMalignant tumors, precision medicinePET/CTPositron emission tomographyTreatment response

Identifiers

PMID36539908
PMCPMC9769012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.